Skip to main content
Advertisement
Advertisement

RMD

RMD logo

ResMed Inc.

218.27
USD
Sponsored
-1.31
-0.60%
Sep 11, 15:59 UTC -4
Closed
exchange

After-Market

218.21

-0.06
-0.03%

RMD Earnings Reports

Positive Surprise Ratio

RMD beat 29 of 42 last estimates.

69%

Next Report

Date of Next Report
Oct 28, 2026
Estimate for Q1 27 (Revenue/ EPS)
$1.38B
/
$2.71
Implied change from Q4 26 (Revenue/ EPS)
-5.93%
/
-8.14%
Implied change from Q1 26 (Revenue/ EPS)
+3.09%
/
+6.69%

ResMed Inc. earnings per share and revenue

On Aug 06, 2026, RMD reported earnings of 2.95 USD per share (EPS) for Q4 26, beating the estimate of 2.91 USD, resulting in a 1.09% surprise. Revenue reached 1.46 billion, compared to an expected 1.47 billion, with a -0.70% difference. The market reacted with a -5.06% price change (close before vs. close after earnings).
Looking ahead to Q1 27, 12 analysts forecast an EPS of 2.71 USD, with revenue projected to reach 1.38 billion USD, implying an decrease of -8.14% EPS, and decrease of -5.93% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Medtronic plc
Report Date
Sep 01, 2026 For Q1 27
Estimate
$1.40
Actual
$1.45
Surprise
+3.45%
FAQ
For Q4 2026, ResMed Inc. reported EPS of $2.95, beating estimates by 1.09%, and revenue of $1.46B, -0.7% below expectations.
The stock price moved down -5.06%, changed from $223.24 before the earnings release to $211.94 the day after.
The next earning report is scheduled for Oct 28, 2026.
Based on 12 analysts, ResMed Inc. is expected to report EPS of $2.71 and revenue of $1.38B for Q1 2027.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement